Results
|
341.
|
|
|
342.
|
Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. [electronic resource] by
- Carden, Marcus A
- Gaddh, Manila
- Hoskote, Abhinav
- Brown, Michael
- Merrill, Virginia
- Stowell, Sean R
- Chandrakasan, Shanmuganathan
- Antun, Ana
- Kudchadkar, Ragini
- Kotanchiyev, Sarah
- Jaye, David L
- Bodó, Imre
Producer: 20210514
In:
Blood advances vol. 4
Availability: No items available.
|
|
343.
|
|
|
344.
|
|
|
345.
|
|
|
346.
|
|
|
347.
|
|
|
348.
|
|
|
349.
|
|
|
350.
|
|
|
351.
|
|
|
352.
|
|
|
353.
|
|
|
354.
|
|
|
355.
|
|
|
356.
|
|
|
357.
|
|
|
358.
|
|
|
359.
|
|
|
360.
|
|